Fengli GAO, Lili SUN, Zhuying LI. Research progress on related mechanism regulation by traditional Chinese herbal medicine in pulmonary fibrosis. [J]. Shanghai Journal of Traditional Chinese Medicine 55(9):91-95(2021)
DOI:
Fengli GAO, Lili SUN, Zhuying LI. Research progress on related mechanism regulation by traditional Chinese herbal medicine in pulmonary fibrosis. [J]. Shanghai Journal of Traditional Chinese Medicine 55(9):91-95(2021) DOI: 10.16305/j.1007-1334.2021.2010012.
Research progress on related mechanism regulation by traditional Chinese herbal medicine in pulmonary fibrosis
The research progress on related mechanism regulation by traditional Chinese herbal medicine in pulmonary fibrosis was reviewed. Studies had found that classical prescriptions, compound prescriptions, monomers and active ingredients played a therapeutic role in pulmonary fibrosis on mediating oxidative/anti-oxidative stress, inhibiting epithelial cell-mesenchymal transition, inhibiting endoplasmic reticulum stress, mediating autophagy, improving extracellular matrix deposition and regulating immune balance.
关键词
中药肺纤维化机制综述
Keywords
traditional Chinese herbal medicinepulmonary fibrosismechanismreview
HIGASHIYAMA H, YOSHIMOTO D, OKAMOTO Y, et al. Receptor-activated Smad localisation in bleomycin-induced pulmonary fibrosis[J]. J Clin Pathol, 2007, 60(3): 283-289.
BAHRI S, BEN ALI R, ABIDI A, et al. The efficacy of plant extract and bioactive compounds approaches in the treatment of pulmonary fibrosis: A systematic review[J]. Biomed Pharmacother, 2017(93): 666-673.
SRIRAM N, KALAYARASAN S, MANIKANDAN R, et al. Epigallocatechin gallate attenuates fibroblast proliferation and excessive collagen production by effectively intervening TGF-β1 signalling[J]. Clin Exp Pharmacol Physiol, 2015, 42(8): 849-859.
RODRIGUEZ L R, BUI S N, BEUSCHEL R T, et al. Curcumin induced oxidative stress attenuation by N-acetylcysteine co-treatment: a fibroblast and epithelial cell in-vitro study in idiopathic pulmonary fibrosis[J]. Mol Med, 2019, 25(1): 27.
YAN B D, MA Z S, SHI S M, et al. Sulforaphane prevents bleomycininduced pulmonary fibrosis in mice byinhibiting oxidative stress via nuclear factor erythroid 2related factor2 activation[J]. Mol Med Rep, 2017, 15(6): 4005-4014.
CHEN J H, SHI Y Y, HE L, et al. Protective roles of polysaccharides from Ganoderma lucidum on bleomycin-induced pulmonary fibrosis in rats[J]. Int J Biol Macromol, 2016(92): 278-281.
WANG K, ZU C H, ZHANG Y, et al. Blocking TG2 attenuatesbleomycin-induced pulmonary fibrosis in mice through inhibiting EMT[J]. Resp Physiol Neurbi, 2020, 276(5): 1-10.
ZHANG R, XU L M, AN X X, et al. Astragalus polysaccharides attenuate pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition and NF-κB pathway activation[J]. Int J Mol Med, 2020, 46(1): 331-339.
SHI Z H, XU L H, XIE H, et al. Attenuation of intermittent hypoxia-induced apoptosis and fibrosis in pulmonary tissues via suppression of ER stress activation[J]. BMC Pulmonary medicine, 2020, 20(1): 301-307.
ARAYA J, KOJIMA J, TAKASAKA N, et al. Insufficient autophagy in idiopathic pulmonary fibrosis[J]. Am J Physiol Lung Cell Mol Physiol, 2013, 304(1): 56-69.
CONG L H, LI T, WANG H, et al. IL-17A-producing T cells exacerbate fine particulate matter-induced lung inflammation and fibrosis by inhibiting PI3K/Akt/mTOR-mediated autophagy[J]. J Cell Mol Med, 2020, 24(15): 8532-8544.
DIVYA T, SURESHKUMAR A, SUDHANDIRAN G. Autophagy induction by celastrol augments protection against bleomycin-induced experimental pulmonary fibrosis in rats: Role of adaptor protein p62/ SQSTM1[J]. Pulm Pharmacol Ther, 2017(45): 47-61.
LIU M W, SU M X, TANG D Y, et al. Ligustrazin increases lung cell autophagy and ameliorates paraquat-induced pulmonary fibrosis by inhibiting PI3K/Akt/mTOR and hedgehog signalling via increasing miR-193a expression[J]. BMC Pulm Med, 2019, 19(1): 35.
ABDEL HALIM A S, AHMED H H, AGLAN H A, et al. Role of bone marrow-derived mesenchymal stem cells in alleviating pulmonary epithelium damage and extracellular matrix remodeling in a rat model of lung fibrosis induced by amiodarone[J]. Biotech Histochem, 2020(95): 1-13.
MOJIRI-FORUSHANI H, HEMMATI A A, KHODADADI A, et al. Valsartan attenuates bleomycin-induced pulmonary fibrosis by inhibition of NF-κB expression and regulation of Th1/Th2 cytokines[J]. Immunopharmacol Immunotoxicol, 2018, 40(3): 225-231.
CHEN H, LLI X, SU Y X, et al. Notch signaling pathway mediates the immunomodulatory mechanism of Yangfei Huoxue decoction alleviating bleomycin-induced pulmonary fibrosis in rats[J]. JTCM, 2020, 40(2): 204-211.